DOVA - Dova Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
Total Revenue
13,732
10,355
0
Cost of Revenue
1,903
1,180
-
Gross Profit
11,829
9,175
-
Operating Expenses
Research Development
18,310
18,304
15,710
Selling General and Administrative
66,512
61,921
13,499
Total Operating Expenses
84,822
80,225
29,209
Operating Income or Loss
-72,993
-71,050
-29,209
Interest Expense
2,554
1,876
1,232
Total Other Income/Expenses Net
-
644
486
Income Before Tax
-74,061
-72,282
-29,955
Income Tax Expense
-
-
-
Income from Continuing Operations
-74,061
-72,282
-29,955
Net Income
-74,061
-72,282
-29,955
Net Income available to common shareholders
-74,061
-72,282
-29,955
Reported EPS
Basic
-
-2.60
-1.40
Diluted
-
-2.60
-1.40
Weighted average shares outstanding
Basic
-
27,803
21,435
Diluted
-
27,803
21,435
EBITDA
-
-70,374
-28,723